Liquid Biopsy

ApoCell offers a comprehensive approach to using liquid biopsies (CTCs, ctDNA, exosomes) to detect and monitor multiple biomarkers using less sample.

Learn More

Immuno-oncology

ApoCell works to integrate today’s leading innovative technologies into one seamless platform technology.

Learn More

Companion Diagnostics

ApoCell’s biomarker-based assays can form the basis for laboratory developed tests and IVDs enhancing therapeutic outcomes.

Learn More

Clinical Trial Support

ApoCell provides biomarker design, sample collection and logistics support, and esoteric testing services across multiple therapeutic areas.

Learn More

Service Partnership

ApoCell partners with organizations involved in accelerating the process of therapeutic development and patient care, including CROS, other analytical labs, and patient advocacy groups.

Learn More

ApoStreams Partnerships

ApoCell is seeking strategic partners for commercialization of its proprietary technology for use in various applications, including oncology, infectious disease, fetal cells, viable cell preservation, bacterial monitoring, regenerative medicine, and therapeutic manufacturing.

Learn More